FDA Orange Book
Is there a generic for Tascenso ODT?
Tascenso ODT contains fingolimod lauryl. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Tascenso ODT (fingolimod lauryl). The Orange Book shows its last listed patent expires January 19, 2036.
Run it in Rivvi
Map Tascenso ODT and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Tascenso ODT products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, orally disintegrating, oral | EQ 0.25MG BASE | Marketed (Rx) | None | 0 | None |
| tablet, orally disintegrating, oral | EQ 0.5MG BASE | Marketed (Rx) | None | 0 | None |
NDA 214962, held by CYCLE PHARMACEUTICALS LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Tascenso ODT patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10555902 | January 19, 2036 | Method of use | U-3268 | 214962 |
| 9925138 | January 19, 2036 | Drug product | None | 214962 |
| 10925829 | January 19, 2036 | Drug product | None | 214962 |
| 10555902 | January 19, 2036 | Method of use | U-3493 | 214962 |
Tascenso ODT NDC codes
Questions
Is there a generic for Tascenso ODT?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Tascenso ODT (fingolimod lauryl). The Orange Book shows its last listed patent expires January 19, 2036.
What is the generic name for Tascenso ODT?
The active ingredient in Tascenso ODT is fingolimod lauryl, per the FDA Orange Book.
When does the Tascenso ODT patent expire?
The last patent listed for Tascenso ODT in the Orange Book expires January 19, 2036. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.